 |
|
| Blog results | Results 1 - 10 of about 1,095 for gemcitabine capecitabine. (0.17 seconds) |
| Sorted by relevance Sort by date |
| 27 Oct 2009 According to research published early online in the Journal of Clinical Oncology, gemcitabine in combination with capecitabine (GEM-CAP) should be considered as one of the standard first-line options in locally advanced and metastatic ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ [ More results from NeLM - News ] |
| 2 Nov 2009 Status: Not yet recruiting, Condition Summary: Adenocarcinoma of Gall Bladder or Biliary Ducts. Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 5 Nov 2009 by Dr. NICK BACKGROUND: No previous prospective trials have been reported with capecitabine and gemcitabine (CAP-GEM) in patients with metastatic thymic epithelial tumors (TETs). We conducted a multicenter study to determine the activity and ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
| 18 Nov 2009 by documentationinnursing ... By Surgery [Conditions: Pancreatic Cancer; Interventions: capecitabine, erlotinib hydrochloride, fluorouracil, gemcitabine hydrochloride, 3-dimensional conformal diffusion psychotherapy, intensity-modulated diffusion therapy] ... documentation in nursing - http://documentationinnursing.start4all.com/ |
| 11 Nov 2009 by Alice Rossiter As has been the pattern for these studies, patients saw little or no benefit from the experimental treatment, in this case, a combination of gemcitabine and capecitabine, as compared with gemcitabine alone. ... Cancer Drug News Editor's Blog - http://cancerdrugnewsblog.blogspot.com/ [ More results from Cancer Drug News Editor's Blog ] |
| 20 Nov 2009 by admin Scheithauer W, Schüll B, Ulrich-Pur H, et al, Gemcitabine alone or in combination with capecitabine in patients with advanced pancreatic adenocarcinoma. Proceedings of the American Society of Clinical Oncology;21:126a, abstract number ... Cancer Treatment Blog - http://www.cancertreatmentblog.com/ |
| 28 Aug 2009 by Crane, Winter, Regine, Safran, Rich, Curran,... Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ - References [ More results from Journal of Clinical Oncology Current Issue ] |
| 23 Sep 2009 Among these clinical trials are three ongoing randomized Phase II studies, including a trial to evaluate Nexavar plus paclitaxel in the first-line setting, a trial to evaluate Nexavar plus gemcitabine or capecitabine in the first- or ... PharmaNews.eu - http://www.pharmanews.eu/component/content/frontpage [ More results from PharmaNews.eu ] |
| 1 Feb 2008 by Boeck, S., Hoehler, T., Seipelt, G., Mahlberg,... Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer ... Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/ [ More results from Annals of Oncology - recent issues ] |
| 15 Oct 2009 by Peter Several agents including taxane, gemcitabine, capecitabine, and becavizumab have been evaluated in MBC patients, either alone or in combination with other cytotoxic agents. Majority of the agents are intravenous drugs. ... Medical Abstract - http://medical-abstract.blogspot.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
